Renovaro Biosciences
RENB
#7734
Rank
A$0.41 B
Marketcap
$2.62
Share price
6.15%
Change (1 day)
-45.16%
Change (1 year)

Renovaro Biosciences (RENB) - Cash on Hand

Cash on Hand as of September 2024 : A$0.35 Million

According to Renovaro Biosciences's latest financial reports the company has A$0.35 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Renovaro Biosciences - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30A$2.83 M-78.76%
2022-06-30A$13.33 M-51.53%
2021-06-30A$27.5 M117.33%
2020-06-30A$12.65 M-27.65%
2019-06-30A$17.49 M-17%
2018-06-30A$21.07 M310.88%
2017-06-30A$5.12 M16295.48%
2016-06-30A$0.03 M
2014-12-31A$3.67 M
2013-03-31A$0 M1900.49%
2012-03-31A$0 M
2011-03-31N/A